Quanta

Avantor® Announces Supplier Award Winners at Americas Sales Conference

Retrieved on: 
Tuesday, April 18, 2023

The Americas Sales Conference is an important forum that strengthens collaboration among suppliers and across Avantor's sales organization to achieve growth opportunities.

Key Points: 
  • The Americas Sales Conference is an important forum that strengthens collaboration among suppliers and across Avantor's sales organization to achieve growth opportunities.
  • Avantor's suppliers are crucial partners, providing expanded choice with innovative and differentiated products that enable customers to continue advancing science from discovery to delivery.
  • The Avantor Supplier Awards recognize winners across a range of categories and product segments.
  • "Every year, I look forward to interacting with all of our suppliers and associates at Avantor's Americas Sales Conference.

Quanta Therapeutics Presents Data from KRAS Inhibitor Pipeline at Annual AACR Meeting in Late-Breaking Research Session

Retrieved on: 
Friday, April 14, 2023

ORLANDO, Fla., April 14, 2023 (GLOBE NEWSWIRE) -- Quanta Therapeutics, a privately-held biopharmaceutical company pioneering targeted therapies to treat RAS-driven cancers, announced data from two late-breaking presentations at the American Association for Cancer Research (AACR) Annual Meeting being held April 14-19, 2023, in Orlando, Florida. QTX3034, a multi-KRAS inhibitor, and QTX3046, a G12D-selective KRAS inhibitor, demonstrate favorable preclinical profiles, including potent anti-tumor activity with oral bioavailability and brain penetration, supporting the initiation of IND-enabling studies and clinical development for KRAS-driven solid tumor indications. Leveraging unique chemistry that targets multiple conformations of KRAS, Quanta Therapeutics' allosteric approach has the potential to expand the scope of treatable KRAS-mutant cancers while evading known mechanisms of KRAS-mediated resistance.

Key Points: 
  • QTX3034, a multi-KRAS inhibitor, and QTX3046, a G12D-selective KRAS inhibitor, demonstrate favorable preclinical profiles, including potent anti-tumor activity with oral bioavailability and brain penetration, supporting the initiation of IND-enabling studies and clinical development for KRAS-driven solid tumor indications.
  • Leveraging unique chemistry that targets multiple conformations of KRAS, Quanta Therapeutics' allosteric approach has the potential to expand the scope of treatable KRAS-mutant cancers while evading known mechanisms of KRAS-mediated resistance.
  • “KRAS G12C inhibitors were a breakthrough for the treatment of cancer patients, but they only address around 10% of KRAS-driven tumors and the duration of clinical benefit is limited.
  • Quanta’s multi-KRAS and G12D-selective inhibitors address a larger portion of the KRAS-mutated patient population.

News Items Adds Mary Williams Walsh and Joanna Thompson to Editorial Team

Retrieved on: 
Tuesday, April 11, 2023

"We're thrilled to have Mary, Joanna and Tom on the News Items team," said John Ellis, the founder and editor of News Items and Political New Items.

Key Points: 
  • "We're thrilled to have Mary, Joanna and Tom on the News Items team," said John Ellis, the founder and editor of News Items and Political New Items.
  • Williams Walsh will oversee daily operations in addition to serving as a financial columnist.
  • Before joining News Items, Williams Walsh worked at The New York Times as a reporter covering the intersection of finance, public policy and the aging population.
  • Ellis recently announced News Items raised $1.5 million during a friends and family round of equity funding.

BAPCo® Introduces Linux and Chrome Support to CrossMark, a Cross-Architecture Performance Benchmark

Retrieved on: 
Wednesday, April 12, 2023

BAPCo®, a non-profit consortium of leading PC hardware manufacturers, add Linux and Chrome support to the CrossMark® v1.0.1.95 benchmark, a cross-architecture performance benchmark using common and relevant workloads.

Key Points: 
  • BAPCo®, a non-profit consortium of leading PC hardware manufacturers, add Linux and Chrome support to the CrossMark® v1.0.1.95 benchmark, a cross-architecture performance benchmark using common and relevant workloads.
  • CrossMark Linux is also available on x86_64 and aarch64 Chromebooks via Linux, aka Crostini or Crosh shell (in developer mode).
  • CrossMark, a cross-platform benchmark available on most popular operating systems, standardizes the process of measuring system performance under real-world usage models.
  • CrossMark reports an overall system performance, as well as several sub-scores indicative of system performance in a variety of real usage models.

MLPerf Inference Delivers Power Efficiency and Performance Gains

Retrieved on: 
Wednesday, April 5, 2023

The latest benchmark results illustrate the industry’s emphasis on power efficiency, with 50% more power efficiency results, and significant gains in performance by over 60% in some benchmark tests.

Key Points: 
  • The latest benchmark results illustrate the industry’s emphasis on power efficiency, with 50% more power efficiency results, and significant gains in performance by over 60% in some benchmark tests.
  • Improving performance and power efficiency will lead the way for deploying more capable AI systems that benefit society.
  • The MLPerf benchmark suites are comprehensive system tests that stress machine learning models including the underlying software and hardware, and in some cases, optionally measuring power efficiency.
  • This round featured even greater participation across the community with a record-breaking 25 submitting organizations, over 6,700 performance results, and more than 2,400 performance and power efficiency measurements.

Hitachi Energy to support the transmission of increasing volumes of sustainable electricity to California

Retrieved on: 
Thursday, March 30, 2023

The selection was made by the Intermountain Power Agency (IPA), which generates electricity in Utah for consumers principally across Utah and California.

Key Points: 
  • The selection was made by the Intermountain Power Agency (IPA), which generates electricity in Utah for consumers principally across Utah and California.
  • (1) This project is important for meeting demand for power in the region and to shift toward more sustainable energy sources.
  • Today, IPP transmits up to 2,400 megawatts (MW) of electricity over 785 km (488 miles) from Delta, Utah to Adelanto, California.
  • Hitachi Energy pioneered commercial HVDC technology almost 70 years ago and has delivered more than half of the world's HVDC projects.

Together with Thousands of Technology and Startup Companies worldwide, COMPUTEX 2023 Visitor Registration is Now Open

Retrieved on: 
Thursday, March 23, 2023

Registration to visit the show opens today; all tech professionals are welcome to register online.

Key Points: 
  • Registration to visit the show opens today; all tech professionals are welcome to register online.
  • In addition, InnoVEX, displaying world startups, is Asia's most iconic startup platform, linking Taiwan's innovative teams with global resources.
  • This year, the speakers come from leading international technology companies, providing attendees with incisive and futuristic technology insights.
  • COMPUTEX 2023 showcases Taiwan's industrial strength and will connect international manufacturers, global technology players, start-up teams, and professional buyers to create unlimited technological possibilities.

Quanta Therapeutics Announces Two Late-Breaking Preclinical Presentations from KRAS Inhibitor Pipeline at Annual AACR Meeting

Retrieved on: 
Tuesday, March 14, 2023

SOUTH SAN FRANCISCO, Calif., March 14, 2023 (GLOBE NEWSWIRE) -- Quanta Therapeutics, a privately-held biopharmaceutical company pioneering complex-directed therapies to treat RAS-driven cancers, today announced the acceptance of two late-breaking abstracts for presentation at the American Association for Cancer Research (AACR) Annual Meeting being held April 14-19, 2023, in Orlando, Florida.

Key Points: 
  • SOUTH SAN FRANCISCO, Calif., March 14, 2023 (GLOBE NEWSWIRE) -- Quanta Therapeutics, a privately-held biopharmaceutical company pioneering complex-directed therapies to treat RAS-driven cancers, today announced the acceptance of two late-breaking abstracts for presentation at the American Association for Cancer Research (AACR) Annual Meeting being held April 14-19, 2023, in Orlando, Florida.
  • Leveraging a differentiated mechanism of action that targets multiple conformations of KRAS, Quanta Therapeutics' allosteric approach has the potential to target the majority of KRAS mutations while evading known mechanisms of resistance.
  • Title: Discovery and characterization of QTX3034, a potent, selective, and orally bioavailable allosteric KRAS inhibitor
    Title: Discovery and characterization of QTX3046, a potent, selective, and orally bioavailable non-covalent KRASG12D inhibitor

Cloud Infrastructure Market Expected to Reach USD 1083.5 Billion by 2030: Verified Market Research

Retrieved on: 
Wednesday, March 1, 2023

JERSEY CITY, N.J., March 1, 2023 /PRNewswire/ -- The global Cloud Infrastructure Market is projected to grow at a CAGR of 18.1% from 2023 to 2030, according to a new report published by Verified Market Research®. The report reveals that the market was valued at USD 241.9 Billion in 2021 and is expected to reach USD 1083.5 Billion by the end of the forecast period.

Key Points: 
  • The report reveals that the market was valued at USD 241.9 Billion in 2021 and is expected to reach USD 1083.5 Billion by the end of the forecast period.
  • The increasing adoption of big data, artificial intelligence, and machine learning, along with cloud platforms, is driving the growth of the cloud infrastructure market.
  • The "Global Cloud Infrastructure Market" is mainly bifurcated into sub-segments which can provide classified data regarding the latest trends in the market.
  • Based on the research, Verified Market Research® has segmented the global Cloud Infrastructure Market into Type, Cloud Type, End-Users, And Geography.

Cloud Infrastructure Market Expected to Reach USD 1083.5 Billion by 2030: Verified Market Research

Retrieved on: 
Wednesday, March 1, 2023

JERSEY CITY, N.J., March 1, 2023 /PRNewswire/ -- The global Cloud Infrastructure Market is projected to grow at a CAGR of 18.1% from 2023 to 2030, according to a new report published by Verified Market Research®. The report reveals that the market was valued at USD 241.9 Billion in 2021 and is expected to reach USD 1083.5 Billion by the end of the forecast period.

Key Points: 
  • The report reveals that the market was valued at USD 241.9 Billion in 2021 and is expected to reach USD 1083.5 Billion by the end of the forecast period.
  • The increasing adoption of big data, artificial intelligence, and machine learning, along with cloud platforms, is driving the growth of the cloud infrastructure market.
  • The "Global Cloud Infrastructure Market" is mainly bifurcated into sub-segments which can provide classified data regarding the latest trends in the market.
  • Based on the research, Verified Market Research® has segmented the global Cloud Infrastructure Market into Type, Cloud Type, End-Users, And Geography.